Filtered news list test

Filtered news list testing

Vectorio® Registration in India, An Innovative Medical Device for cTACE Procedures

Read the article

New indication approved for Guerbet’s Lipiodol® Ultra Fluid

Read the article

1 st quarter 2019 revenue

Read the article

Guerbet announces a strategic partnership with InterSystems to extend the deployment of Contrast&Care®

Read the article

Guerbet to present its innovative solution offering for interventional imaging at CIRSE 2019 Barcelona from September 7-11, 2019

Read the article

Guerbet signs an agreement with icometrix for the exclusive distribution of icobrain, an artificial intelligence medical imaging solution for neuro imaging

Read the article

Guerbet gana el PI-CAI Grand Challenge sobre detección de cáncer de próstata…

Guerbet and IBM Watson Health announce a second co-development project as part of their strategic partnership for leveraging artificial intelligence in medical imaging

Read the article

2018 revenue

Read the article

2019 half-year results

Read the article

11
12
13
14
Current page15
16
17
18
19

Single report testing

.pdf

test report fabien V 09-07

Separator

Filtered images

David Hale, CEO Of Guerbet ©Eric LARRAYADIEU

Life At Work At Guerbet HQ ©Eric LARRAYADIEU

Artificial Intelligence And Physician

CT Procedure With Optivantage Multi Use 01

C TACE Procedure With Injection And Emulsion

Guerbet Fill And Finish Site At Aulnay © Patrick Allard REA

Life At Work At Guerbet HQ (2) ©Eric LARRAYADIEU

Guerbet Fill And Finish Site At Aulnay (2) © Patrick Allard REA

Manual news 1

subtitle

item 1 text

item 1 title

Link text

Manual news 2

item 1 text

item 1 title

link

item 2 title

Teest

Discover the latest news of Guerbet

U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT

Read the press release

2024 revenue

Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow^®, innovative solution dedicated to oncology imaging

Read the press release

UNIK: Diagnostic Imaging Interconnected Solutions

UNIK: Diagnostic Imaging Interconnected Solutions

UNIK: Diagnostic Imaging Interconnected Solutions

Interventional Imaging Solutions

Women’s Health

Filtered news list testing

Vectorio® Registration in India, An Innovative Medical Device for cTACE Procedures

New indication approved for Guerbet’s Lipiodol® Ultra Fluid

1 st quarter 2019 revenue

Guerbet announces a strategic partnership with InterSystems to extend the deployment of Contrast&Care®

Guerbet to present its innovative solution offering for interventional imaging at CIRSE 2019 Barcelona from September 7-11, 2019

Guerbet signs an agreement with icometrix for the exclusive distribution of icobrain, an artificial intelligence medical imaging solution for neuro imaging

Guerbet and IBM Watson Health announce a second co-development project as part of their strategic partnership for leveraging artificial intelligence in medical imaging

2018 revenue

2019 half-year results

List of Reports

04/27/2017 - Revenue at 1st quarter 2017

06/04/2017 - Registration document 2016

03/29/2017 - Annual results 2016 (presentation)

03/29/2017 - Annual results 2016

02/15/2017 - Annual revenue 2016

10/24/2016 - Revenue at 3rd quarter 2016

10/10/2016- Annual revenue 2015

09/28/2016 - Half-year results 2017 (presentation)

Single report testing

test report fabien V 09-07

Separator

Filtered images

Manual news 1

item 1 title

Manual news 2

item 1 title

item 2 title

Discover the latest news of Guerbet

U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT

2024 revenue

Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow^®, innovative solution dedicated to oncology imaging

UNIK: Diagnostic Imaging Interconnected Solutions

UNIK: Diagnostic Imaging Interconnected Solutions

UNIK: Diagnostic Imaging Interconnected Solutions

Interventional Imaging Solutions

Women’s Health

Filtered news list testing

Vectorio® Registration in India, An Innovative Medical Device for cTACE Procedures

New indication approved for Guerbet’s Lipiodol® Ultra Fluid

1 st quarter 2019 revenue

Guerbet announces a strategic partnership with InterSystems to extend the deployment of Contrast&Care®

Guerbet to present its innovative solution offering for interventional imaging at CIRSE 2019 Barcelona from September 7-11, 2019

Guerbet signs an agreement with icometrix for the exclusive distribution of icobrain, an artificial intelligence medical imaging solution for neuro imaging

Guerbet and IBM Watson Health announce a second co-development project as part of their strategic partnership for leveraging artificial intelligence in medical imaging

2018 revenue

2019 half-year results

List of Reports

04/27/2017 - Revenue at 1st quarter 2017

06/04/2017 - Registration document 2016

03/29/2017 - Annual results 2016 (presentation)

03/29/2017 - Annual results 2016

02/15/2017 - Annual revenue 2016

10/24/2016 - Revenue at 3rd quarter 2016

10/10/2016- Annual revenue 2015

09/28/2016 - Half-year results 2017 (presentation)

Single report testing

test report fabien V 09-07

Separator

Filtered images

Manual news 1

item 1 title

Manual news 2

item 1 title

item 2 title

Discover the latest news of Guerbet

U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT

2024 revenue

Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging

Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow^®, innovative solution dedicated to oncology imaging